Beijing HyperStrong Technology
688411
Yalian Machinery
001395
Merit Interactive
300766
4
Pansoft
300996
5
Sublime China Information
301299
CN Stock MarketDetailed Quotes
300683 Wuhan Hiteck Biological Pharma
- 22.28
- +0.13+0.59%
Market Closed Jan 27 15:00 CST
2.92BMarket Cap-21.74P/E (TTM)
22.76High22.15Low8.50KlotVolume22.37Open22.15Pre Close19.12MTurnover0.70%Turnover RatioLossP/E (Static)130.89MShares32.6552wk High1.20P/B2.72BFloat Cap18.6752wk Low26.58Limit Up122.06MShs Float84.71Historical High17.72Limit Down2.75%Amplitude18.67Historical Low0.13Dividend TTM22.49Avg Price3.95KlotAsk0.58%Div YieldTTM100Lot Size4.30KlotBid
Wuhan Hiteck Biological Pharma News
Haite Biotech: 2024 performance forecast
Haite Biotech: Report for the third quarter of 2024
Haite Biotech: 2024 Semi-Annual Report Summary
Haite Biotech: 2024 Semi-Annual Report
Haite Biotech: 2023 Annual Report Summary
Haite Biotech: 2023 Annual Report
Haite Biotech: Report for the first quarter of 2024
Haite Biotech: 2023 performance forecast
Haite Biotech: Report for the third quarter of 2023
Haite Biotech: Semi-Annual Report 2023
Haite Biotech: Summary of the 2023 Semi-Annual Report
Hyte Biotech: 2022 Annual Report
Hyte Biotech: Report for the first quarter of 2023
Hyte Biotech: 2022 Annual Report Summary
Haite Biotech: 2022 Annual Results Forecast
Hyte Biotech: Report for the third quarter of 2022
Haite Biotech: 2022 Semi-Annual Report of Wuhan Haite Biopharmaceutical Co., Ltd. (after correction)
Hyte Biotech: 2022 Semi-Annual Report
Hyte Biotech: 2022 Semi-Annual Report Summary
Hyte Biotech: Report for the first quarter of 2022